- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
- Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
More ▼
Key statistics
On Friday, Enzo Biochem Inc (ENZ:NYQ) closed at 1.19, 20.19% above the 52 week low of 0.9901 set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.19 |
---|---|
High | 1.23 |
Low | 1.13 |
Bid | 1.13 |
Offer | 1.28 |
Previous close | 1.16 |
Average volume | 162.39k |
---|---|
Shares outstanding | 51.23m |
Free float | 38.83m |
P/E (TTM) | -- |
Market cap | 60.96m USD |
EPS (TTM) | -0.4699 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:10 BST.
More ▼